News | February 19, 2010

C-Reactive Protein Not Ideal in Testing for Heart Disease

February 19, 2010 – For women concerned about heart disease, routine testing of high-sensitivity C-reactive protein (hs-CRP) is controversial, said Thomas Behrenbeck, M.D., Ph.D., a Mayo Clinic cardiologist, in an interview in the February issue of Mayo Clinic Women’s HealthSource.

CRP is a marker for inflammation within the body and has been promoted as a screening test for coronary artery disease. Inflammation can play an important role in atherosclerosis. Interest in hs-CRP originated when studies found that patients with unstable angina or chest pain had high levels of this marker. Researchers found that hs-CRP could be used to predict who would go on to have a heart attack. But other studies have shown that hs-CRP isn’t a predictor of heart attack risk in people without symptoms of heart disease.

“If hs-CRP is elevated, it is worrisome because it tells you there is inflammation in the body,” Dr. Behrenbeck said. “But it doesn’t mean the inflammation is related to coronary artery disease.” Inflammation can be a response to any type of injury or infection. People who have rheumatoid arthritis have very high levels of hs-CRP. Elevated levels also can be caused by a bruise or a minor surgical procedure such as a tooth extraction.

For now, Dr. Behrenheck said there is no good role for hs-CRP screening in patients without symptoms of coronary artery disease. “We’ve been unable to determine if knowing your hs-CRP level is helpful beyond all of the other traditional risk factors – such as high blood pressure, diabetes, smoking and high cholesterol,” he said.

He advises women to continue to focus on the traditional risk factors. Controlling these risk factors is especially important post-menopause, when a woman’s risk of coronary heart disease increases.
Mayo Clinic Women’s HealthSource is published monthly to help women enjoy healthier, more productive lives. Revenue from subscriptions is used to support medical research at Mayo Clinic.

For more information: www.bookstore.mayoclinic.com

Related Content

Florida Medical Center First in State to Offer High Sensitive STAT Blood Test
News | Blood Testing| September 07, 2017
In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U...
Patients With Low Corus CAD Test Score Less Likely to Undergo Cardiac Referra
News | Blood Testing| May 02, 2017
CardioDx Inc. recently announced the publication of results from the multi-center, community-based PRESET Registry in...
New Blood Test Predicts Major Cardiac Events Better Than Clinical Evaluation of Other Common Risk Factors
News | Blood Testing| April 28, 2017
Prevencio Inc. announced the publication of data demonstrating that a simple new blood test is more accurate than...
New Study Pursues Universal Sample Bank for Troponin Tests
News | Blood Testing| April 13, 2017
April 13, 2017 — A study published recently in the American Association for Clinical Chemistry’s (AACC)...
PTS Diagnostics, FDA 510k clearance, extended HDL range, lipid panel test strips
News | Blood Testing| April 05, 2017
PTS Diagnostics announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded top range for...
heart attack evaluation, blood test, HEART Score, ER, emergency room, Circulation Cardiovascular Quality and Outcomes study
News | Blood Testing| March 01, 2017
Up to 40 percent of emergency room (ER) patients with chest pain can safely go home in a little under 2 hours, using a...
troponin blood test, heart disease risk, heart attack, British Heart Foundation, BHF
News | Blood Testing| January 04, 2017
A high-sensitivity blood test could be used to predict which patients are at risk of a heart attack according to new...
Alere, INRatio PT/INR Monitor, voluntary recall, FDA
News | Blood Testing| July 12, 2016
July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc.
News | Blood Testing| March 22, 2016
March 22, 2016 — Critical Diagnostics announced that it entered into a license agreement for the exclusive worldwide
Overlay Init